Most Recent
Merger to create $285M IP firm poised for Asia push
The companies that own some of Australia's largest intellectual property boutiques have agreed to a merger that will create a 349 employee-strong firm that's a force to be reckoned with in the market for IP services in Asia Pacific.
Elle publisher wins opposition to Aussie builder’s ‘Ella’ trade mark
The Paris-based publisher of Elle Magazine has succeeded in a challenge to a trade mark application by an Australian building supplier for the name of its brand of bathroom fixtures, 'Ella'.
Dr Reddy’s settles Millennium’s cancer drug patent suit
Generic drug maker Dr Reddy's Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.
Mars melts Kraft’s patent for heat-resistant chocolate
Confectionery giant Mars has successfully opposed an application by Kraft Foods for an Australian patent for chocolate that doesn't melt in the summer months.
Inhibox maker used Allergan’s Botox trade mark for comparison’s sake, court hears
The company that manufactures Botox alternatives has denied infringing on Allergan's Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.
Millennium wins injunction against Juno over generic cancer drug
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.
Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy's Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.
Patent suits launched over breakthrough cancer drug
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.
Aristocrat fights ruling dismissing its patents as ‘game rules’
Aristocrat Technologies is pushing on with its bid for four innovation gaming patents, after a delegate for IP Australia revoked the patents because they amounted to nothing more than 'games and game rules'.
IP Australia revokes four Aristocrat Technologies gaming patents
IP Australia has revoked four innovation gaming patents held by Aristocrat Technologies related to the use of configurable symbols in a game, saying the inventions didn't amount to anything other than games and game rules.